About

Profile Max Peters

My Name is Maximilian Peters

I am a PhD trained neurobiologist with a MSc in pharmaceutical chemistry who loves small molecules, their chemistry, using computers to solve scientific questions and just science in general.

Projects

Hemi-NeSTR

Turbo batch primer design for targeted STR genotyping of single cells.
Server is available here: Hemi-NeSTR

Work

For my professional profile, please have a look at my LinkedIn profile.

Publications

Depletion of Membrane Cholesterol Suppresses Drosophila Transient Receptor Potential-Like (TRPL) Channel Activity

Curr Top Membr. 2017;80:233-254

Ectopic Expression of Mouse Melanopsin in Drosophila Photoreceptors Reveals Fast Response Kinetics and Persistent Dark Excitation

J Biol Chem. 2017 Mar 3;292(9):3624-3636

Functional cooperation between the IP3 receptor and phospholipase C secures the high sensitivity to light of Drosophila photoreceptors in vivo

J Neurosci. 2015 Feb 11;35(6):2530-46

The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14

FASEB J. 2014 Mar;28(3):1181-97

Drosophila TRP and TRPL are assembled as homomultimeric channels in vivo

J Cell Sci. 2013 Jul 15;126(Pt 14):3121-33

Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice

J Neurotrauma. 2012 Dec 10;29(18):2831-4

Cell biology. Rhodopsin as thermosensor?

Science. 2011 Mar 11;331(6022):1272-3

Linoleic acid inhibits TRP channels with intrinsic voltage sensitivity: Implications on the mechanism of linoleic acid action

Channels (Austin). 2009 May-Jun;3(3):164-6

Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels

Cell Calcium. 2009 Mar;45(3):300-9

HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity

Expert Opin Investig Drugs. 2007 Sep;16(9):1405-13

Cannabidiol--recent advances

Chem Biodivers. 2007 Aug;4(8):1678-92

A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study

J Pharmacol Exp Ther. 2007 Aug;322(2):646-53

Contact

Contact Details

Maximilian Peters
Horemansstr. 1
80636 M√ľnchen
Germany
info@mpeters.net